Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Collet

Showing results (241-250 of 408) with videos related to

Pageof 41
Sort By:
European Heart Journal|January 25, 2018
Periprocedural myocardial infarction and injury in elective coronary stentingMichel Zeitouni, Johanne Silvain, Paul Guedeney, et al.
Archives of Cardiovascular Diseases|March 3, 2020
Effect of oral anticoagulation on clinical outcomes and haemodynamic variables after successful transcatheter aortic valve implantationPaul Guedeney, François Huchet, Thibaut Manigold, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 6, 2018
Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life supportPavel Overtchouk, Julien Pascal, Guillaume Lebreton, et al.
Archives of Cardiovascular Diseases|May 8, 2022
Evolution of TAVI patients and techniques over the past decade: The French TAVI registriesRomain Didier, Herve Le Breton, Hélène Eltchaninoff, et al.
The American Journal of Cardiology|October 9, 2012
Prasugrel monitoring and bleeding in real world patientsGuillaume Cayla, Thomas Cuisset, Johanne Silvain, et al.
International Journal of Cardiology|September 16, 2018
Copeptin as a prognostic biomarker in acute myocardial infarctionBenoit Lattuca, Vuthy Sy, Lee S Nguyen, et al.
International Journal of Cardiology|April 4, 2015
Impact of prolonged dual antiplatelet therapy after acute myocardial infarction on 5-year mortality in the FAST-MI 2005 registryFrancois Schiele, Etienne Puymirat, Laurent Bonello, et al.
American Heart Journal|January 22, 2023
βeta blocker interruption after uncomplicated myocardial infarction: rationale and design of the randomized ABYSS trialJohanne Silvain, Guillaume Cayla, Emile Ferrari, et al.
European Heart Journal|January 10, 2017
Platelet reactivity in human immunodeficiency virus infected patients on dual antiplatelet therapy for an acute coronary syndrome: the EVERE2ST-HIV studyMarie Hauguel-Moreau, Franck Boccara, Anders Boyd, et al.
Archives of Cardiovascular Diseases|January 10, 2019
Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collaboration with the French Society for Anaesthesia and Intensive Care (SFAR)Anne Godier, Dephine Garrigue, Dominique Lasne, et al.
Pageof 41

Showing results (241-250 of 408) with videos related to

Sort By:
Pageof 41
European Heart Journal|January 25, 2018
Periprocedural myocardial infarction and injury in elective coronary stentingMichel Zeitouni, Johanne Silvain, Paul Guedeney, et al.
Archives of Cardiovascular Diseases|March 3, 2020
Effect of oral anticoagulation on clinical outcomes and haemodynamic variables after successful transcatheter aortic valve implantationPaul Guedeney, François Huchet, Thibaut Manigold, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 6, 2018
Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life supportPavel Overtchouk, Julien Pascal, Guillaume Lebreton, et al.
Archives of Cardiovascular Diseases|May 8, 2022
Evolution of TAVI patients and techniques over the past decade: The French TAVI registriesRomain Didier, Herve Le Breton, Hélène Eltchaninoff, et al.
The American Journal of Cardiology|October 9, 2012
Prasugrel monitoring and bleeding in real world patientsGuillaume Cayla, Thomas Cuisset, Johanne Silvain, et al.
International Journal of Cardiology|September 16, 2018
Copeptin as a prognostic biomarker in acute myocardial infarctionBenoit Lattuca, Vuthy Sy, Lee S Nguyen, et al.
International Journal of Cardiology|April 4, 2015
Impact of prolonged dual antiplatelet therapy after acute myocardial infarction on 5-year mortality in the FAST-MI 2005 registryFrancois Schiele, Etienne Puymirat, Laurent Bonello, et al.
American Heart Journal|January 22, 2023
βeta blocker interruption after uncomplicated myocardial infarction: rationale and design of the randomized ABYSS trialJohanne Silvain, Guillaume Cayla, Emile Ferrari, et al.
European Heart Journal|January 10, 2017
Platelet reactivity in human immunodeficiency virus infected patients on dual antiplatelet therapy for an acute coronary syndrome: the EVERE2ST-HIV studyMarie Hauguel-Moreau, Franck Boccara, Anders Boyd, et al.
Archives of Cardiovascular Diseases|January 10, 2019
Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collaboration with the French Society for Anaesthesia and Intensive Care (SFAR)Anne Godier, Dephine Garrigue, Dominique Lasne, et al.
Pageof 41